No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Pembrolizumab improves long-term survival in patients with stage III melanoma

byTeddy Guo

May 5, 2021

in StudyGraphics

Reading Time: 1 min read

Convalescent plasma transfusion provides mortality benefit in early COVID-19 disease stage

RelatedReports

The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Fall boosters, mosquitoes, skin awareness, and Hollywood healing

August 28, 2025

Dermatology

Microneedling with tranexamic acid may improve outcomes for patients with melasma

August 26, 2025

Elective neck dissection may be unnecessary for adenoid cystic carcinoma

Oncology

Pembrolizumab improves survival in locally advanced head and neck cancer

August 26, 2025

StudyGraphics

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

July 9, 2025

Quick Take: Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent)

Sonelokimab 120 mg or less showed significant clinical benefit over placebo in patients with plaque psoriasis

#VisualAbstract: ChAdOx1 nCov-19 AstraZeneca COVID-19 vaccine not effective against B.1.351 variant

Addressing non-obesity related barriers may improve bariatric surgery effectiveness

Coronary microvascular dysfunction demonstrating improvement after surgery for inflammatory bowel disease

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports